This article outlines the importance of distinguishing between different forms of myopathies, including nectrotizing myopathy. Arthritis & Rheumatism Research News Alerts
Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The safety profile was good, and the level of response often increased as treatment went on, the researchers report. Reuters Health Information
Drugs that inhibit tumor necrosis factor provide considerable benefit in treatment of rheumatoid arthritis; however, there is an unmet medical need for alternative therapies. Nature Clinical Practice Rheumatology
